XStor Medical Systems has launched an image-management and storage system that enables the secure exchange of patient information, images and videos between doctors and patients in hospitals, clinics and other health care facilities. The XStor Imaging Platform system is compatible with multiple modalities and existing infrastructure, the company said.

According to a study published in the Journal of the American Medical Association, people under Medicare are more likely to survive the first 30 days after a heart attack than they would have done more than a decade ago. The people are also likely to find more consistent quality of care among hospitals in terms of its treatment of heart attack survivors.

Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report investigators from Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute and Brigham and Women’s Hospital. The study, published on August 12 issue of the Journal of the American Medical Association, also indicated that the aspirin-associated survival advantage was seen primarily in patients with tumors expressing the COX-2 enzyme, a characteristic of two-thirds of colorectal cancers. The researchers had compiled data from two ongoing prospective research studies, the Nurses Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS).

Vystar and Alatech Healthcare have received 510(k) clearance from the FDA to market and sell the first exam gloves manufactured with Vytex Natural Rubber Latex (NRL). Vystar’s patented Vytex NRL is an environmentally friendly material that contains virtually undetectable levels of the antigenic proteins that cause allergic response. Vytex NRL retains and improves on the desirable qualities of latex. Alatech’s exam gloves made with Vytex will carry the protein label claim of 50 µg/dm2 or less of total extractable protein per glove.